NCT03456349View on ClinicalTrials.gov

Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 10, 2017

Primary Completion Date

July 16, 2018

Study Completion Date

July 16, 2018

Conditions
Alzheimer's Disease
Interventions
DRUG

HTL0018318

HTL0018318

DRUG

Placebo

Placebo

Trial Locations (4)

Unknown

Syneos, Prague

Syneos, Warsaw

Syneos, Bratislava

Syneos, Barcelona

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Nxera Pharma UK Limited

INDUSTRY

NCT03456349 - Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care | Biotech Hunter | Biotech Hunter